Catalyst Wire Dossier Catalyst Wire Dossier

Allogenic Umbilical Cord-Derived Mesenchymal Stem Cells

mesenchymal stem cells · Seoul National University Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogenic Umbilical Cord-Derived Mesenchymal Stem Cells, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease

See pricing